Structures with a second nitrogen atom ( [1, 3] or [2, 4] benzodiazepines, X=N, n=0, 1, m=1, 2)
are described 3-8 but we have found one report 9 concerning compounds with an oxygen atom ( [3, 1] benzoxazepine, X=O, n=0, m=2) and no report with a sulfur atom. Similarly, isoindolobenzodiazocine (X=NH, n+m=3), oxazocine (X=O, n+m=3) or thiazocine (X=S, n+m=3) are just now unknown.
As a further development of our search on tetracyclic systems we hope to synthesize polycyclic systems as 1 (X=O, S, NH, n=l, m=2). For this purpose, substituted isoindolones 6, 7 or 8 could be the precursors and we wish to describe herein their synthesis.
Since it is well known that hydroxylactam can give a substitution product 10 Hydroxylactams 2a-d (10 mmol) and thioglycolic acid (0.83 ml, 1.1 g, 12 mmol) were refluxed overnight in acetic acid. The solvent was evaporated and the solid was triturated with ether, filtered, then recrystallized from acetone. 
3-(Carboxymethylthio)-2,3-dihydro-2-phenyl-1H-isoindol-1-one (6a

3-(Carboxymethylthio)-2,3-dihydro-2-(thien-2'-ylmethyl)-1H-isoindol-1-one (6b
3-(Carboxymethylthio)-2,3-dihydro-2-(thien-3'-ylmethyl)-1H-isoindol-1-one (6c
3-(Ethoxycarbonylmethylthio)-2,3-dihydro-2-(thien-2'-ylmethyl)-1H-isoindol-1-one (3b).
Preparation of aminolactams 10a-d : general procedure.
A solution of ammonia in dichloromethane was prepared by extraction of 400 ml of concentrated aqueous ammonia solution with 400 ml of dichloromethane. The aqueous layer was kept in the separatory funnel for later use and the solution of ammonia in dichloromethane was dried over magnesium sulfate then filtered. 
3-Amino-2,3-dihydro-2-phenyl-1H-isoindol-1-one (10a
3-Amino-2,3-dihydro-2-(thien-2'-ylmethyl)-1H-isoindol-1-one (10b
3-Amino-2,3-dihydro-2-(thien-3'-ylmethyl)-1H-isoindol-1-one (10c
Preparation of glycine derivatives 8a-d
Aminolactams 10a-d (10 mmol), potassium carbonate (6.4 g, 20 mmol), ethyl bromoacetate (2.2 ml, 20 mmol) and 20 ml of dry 1,4 dioxane were refluxed for 5 days. After removal of the solvent, water and dichloromethane were added to the residue. The organic layer was washed with 5% aqueous hydrochloric solution (no extraction of desired product), washed with water, dried, then evaporated. The residue was chromatographed with dichloromethane to afford esters 5a-d as an oil. These crude esters, potassium carbonate (2.4 g), water (6 ml) and methanol (24 ml) were stirred under reflux for 2 hours, then the solution was concentrated under reduced pressure. Water and dichloromethane were added and the organic layer was discarded. The aqueous layer was washed with dichloromethane and acidified with hydrochloric acid (10%) to pH=2. Compounds 8a-d were rapidly extracted with dichloromethane before crystallization occurs. After removal of the solvent, the residue was recrystallized from acetone to give pure 8a-d.
3-(Carboxymethylamino)-2,3-dihydro-2-phenyl-1H-isoindol-1-one (8a).
Yield 
3-(Carboxymethylamino)-2,3-dihydro-2-(thien-2'-ylmethyl)-1H-isoindol-1-one (8b).
Preparation of glycolic derivatives 7a-d
Hydroxylactams 2a-d (10 mmol) were dissolved in 50 ml of dry tetrahydrofuran and BuLi (7 ml, 1.6 M, 1.1 eq) was added with stirring. Then a solution of 1.7 ml (15 mmol) of ethyl bromoacetate in 10 ml of dry hexamethylphosphoramide was added. Stirring was continued overnight, then the solution was poured into water then extracted with dichloromethane. The organic layer was washed with water then evaporated. The oil was triturated several times with water and decanted. The oil was dried under reduced pressure then chromatographed with dichloromethane. The ester 4a-d was obtained as an oil. Saponification of esters 4a-d was performed in a similar manner as above and led to acids 7a-d which were recrystallized from acetone. 
3-(Carboxymethyloxy)-2,3-dihydro-2-phenyl-1H-isoindol-1-one (7a
